TNF and major depressive disorder: Furthermore, an earlier in vivo study using a chronic stress rat model of depression (Grundmann et al., 2010) showed that an administration of STW3-VI decreased the stress-induced TNF levels in plasma, providing novel evidence that the mechanism of STW3-VI action involves the link between immune-/neuroendocrine systems and oxidative stress defense.